Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early stage breast cancer would result in equivalent surv...
Saved in:
Main Authors: | Jaime D. Lewis (Author), Anees B. Chagpar (Author), Elizabeth A. Shaughnessy (Author), Jacob Nurko (Author), Kelly McMasters (Author), Michael J. Edwards (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2014-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombosis of acute superior mesenteric artery in a patient with breast cancer receiving toremifene therapy: a case report and literature review
by: Ximei Wang, et al.
Published: (2024) -
CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients
by: Sirachainan E, et al.
Published: (2012) -
Bilateral ovarian endometriomas after laparoscopic hysterectomy following adjuvant tamoxifen therapy for breast cancer: A case report
by: Satoshi Nishiyama, et al.
Published: (2022) -
Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023) -
A Reconsideration Of Tamoxifen Use for Breast Cancer
by: Peng-Hui Wang, et al.
Published: (2007)